Brief: Lava Therapeutics To Present Updated Data From The Phase 1/2A Clinical Trial Of Lava-051 At The 64Th American Society Of Hematology (Ash) Annual Meeting And Exposition

LAVA Therapeutics NV

03/11/2022 14:07

Nov 3 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA THERAPEUTICS TO PRESENT UPDATED DATA FROM THE PHASE
1/2A
CLINICAL TRIAL OF LAVA-051 AT THE 64TH AMERICAN SOCIETY OF
HEMATOLOGY (ASH) ANNUAL MEETING AND EXPOSITION

Source text for Eikon:  ID:nGNX8jS17Q 
Further company coverage:  LVTX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))